Previous Page  58 / 63 Next Page
Information
Show Menu
Previous Page 58 / 63 Next Page
Page Background

VISTA is a potent inhibitory checkpoint that is predominantly expressed on CD68+

macrophages on PDACs.

VISTA may be a relevant immunotherapy target for effective treatment of patients

with pancreatic cancer.

VISTA (V-domain immunoglobulin suppressor of T cell activation)

1

Blando J, et al. PNAS 2019